Buy New

or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
Buy Used
Used - Good See details
$2.21 & eligible for FREE Super Saver Shipping on orders over $25. Details

or
Sign in to turn on 1-Click ordering.
 
   
More Buying Choices
Have one to sell? Sell yours here
Tamoxifen and Breast Cancer (Yale Fastback Series)
 
 
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Tamoxifen and Breast Cancer (Yale Fastback Series) [Paperback]

Dr. Michael W. DeGregorio (Author), Valerie J. Wiebe (Author)

Price: $18.00 & eligible for FREE Super Saver Shipping on orders over $25. Details
  Special Offers Available
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Only 1 left in stock--order soon.
Want it delivered Monday, January 30? Choose One-Day Shipping at checkout. Details
Textbook Student FREE Two-Day Shipping for Students. Learn more

Formats

Amazon Price New from Used from
Hardcover $39.00  
Paperback $13.95  
Paperback, September 10, 1994 $18.00  
There is a newer edition of this item:
Tamoxifen and Breast Cancer (Yale Fastback Series) Tamoxifen and Breast Cancer (Yale Fastback Series)
$13.95
In Stock.

Book Description

0300059922 978-0300059922 September 10, 1994 1
Tamoxifen is one of the most widely prescribed drugs used to prevent the recurrence of breast cancer. A non-steroidal antiestrogen, it has been successful in treating postmenopausal women at nearly all stages of breast cancer. Despite its popularity, however, disturbing questions remain about the use of this drug. How effective is tamoxifen in treating patients who have hormone-insensitive breast tumours or who have not yet reached menopause? What are the potential risks in taking tamoxifen, and do they ever outweigh its benefits? Should tamoxifen be administered as a prophylactic drug for healthy premenopausal women who are at high risk of developing breast cancer? In this book, two leading scientific investigators present a balanced and accessible discussion of the diagnosis of breast cancer and the risks, benefits, and limitations of treatment alterntives, particularly tamoxifen. Michael W. DeGregorio and Valerie Wiebe discuss the history and evolution of tamoxifen as a treatment for breast cancer, explaining how it works, what its side effects are, and why tamoxifen treatment is unsuccessful for some women. They present the controversies surrounding the National Cancer Institute's study of tamoxifen as a preventive for breast cancer, describing the hopes of the proponents of the study and the fears of its detractors (potential risks to womcn in the study include thrombosis, uterine cancer, and even breast cancer itself). The book is also an aid to women faced with decisions about treatment or prevention of breast cancer.

Special Offers and Product Promotions

  • Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)


Product Details


More About the Author

Discover books, learn about writers, read author blogs, and more.

Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Inside This Book (learn more)
Browse and search another edition of this book.
First Sentence:
A diagnosis of breast cancer is one of the greatest fears among women. Read the first page
Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
mild chemotherapy, tamoxifen resistance, premenopausal patients, tamoxifen group, tamoxifen therapy, women taking tamoxifen, tamoxifen trial, postmenopausal patients, developing endometrial cancer, breast cancer recurrence, breast cancer cells, chemoprevention trial, developing breast cancer, partial mastectomy, tamoxifen treatment, hormonal agents, adjuvant tamoxifen, early breast cancer
Key Phrases - Capitalized Phrases (CAPs): (learn more)
National Cancer Institute
New!
Books on Related Topics | Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Search Inside This Book:




Suggested Tags from Similar Products

 (What's this?)
Be the first one to add a relevant tag (keyword that's strongly related to this product).
 
(17)

Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums





Look for Similar Items by Category


Look for Similar Items by Subject